News

Focus on dedicated brain PET systems at ECCN 2022

March 17, 2022
Experts agree that the need for dedicated brain PET systems increases significantly if disease-modifying therapies or disease-preventing drugs for Alzheimer’s disease become available.

Positrigo among top 50 of the W.A. de Vigier Foundation

January 25, 2022
Positrigo is among the top 50 companies competing for the W.A. de Vigier Foundation Award 2022.

Positrigo selected for IMD Startup Competition 2021/2022

December 17, 2021
Positrigo is among 37 companies which have been selected to participate in the 2021/2022 IMD Startup Competition

Positrigo and Bottneuro sign collaboration agreement

November 2, 2021
The two Swiss based companies Positrigo and Bottneuro have announced a cooperation

Positrigo certified for ISO13485:2016

September 27, 2021
Positrigo demonstrates commitment to provide medical devices and related services…

Visit by Minister President of Saxony

September 10, 2021
Last week Michael Kretschmer who serves currently as the Minister President of Saxony (Germany) and a delegation visited us

Performance of the Ultra-Compact Fully Integrated Brain PET System BPET

September 1, 2021
Positrigo reports about preliminary performance data of the BPET device which serves as prototype for the NeuroLF® brain PET scanner.

Successful exploratory clinical study with ultracompact brain PET device

July 28, 2021
Positrigo reports completion of the ExploreBPET clinical study, using the novel investigational medical device BPET for imaging of the human brain.

Financial boost for Positrigo

July 15, 2021
Positrigo receives funding from the European Innovation Council (EIC Fund) for its breakthrough brain PET scanner technology.

Positrigo appoints VP Business Development and Marketing

June 3 2021
Positrigo appoints Dr. Stefan Bircher as new VP Business Development and Marketing.